NetworkNewsBreaks

ThursdayJan 05, 2023 12:34 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at Virtual Investor 2023 ‘Companies to Watch’

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company today announced that its Chief Executive Officer John Climaco will present at the Virtual Investor 2023 “Companies to Watch” event. Climaco’s presentation is scheduled to take place beginning at 10 a.m. ET on Wednesday, Jan. 18, 2023. A live video webcast of the presentation will be available on the Events page of CNS Pharmaceuticals’ website, and a replay will be available two hours following the live presentation and accessible for 90…

Continue Reading

ThursdayJan 05, 2023 12:26 pm

NetworkNewsBreaks – MetAlert Inc. (MLRT) Issues Shareholder Update

MetAlert (OTC: MLRT), a pioneer in location-sensitive health monitoring devices and wearable technology products for remote patient monitoring, today issued its year-end shareholder letter. In the update, the company’s CEO and Founder Patrick Bertagna shared insight on the company’s restructuring, branding and efforts to attract new investors and larger customers to execute its growth strategy, as well as the milestones that will shape MetAlert’s future. “We are now taking dramatic steps to align the public-facing (stock) part of the company with the operations and vision of the company. Although the short-term performance of the stock has not been what we…

Continue Reading

ThursdayJan 05, 2023 11:22 am

NetworkNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Releases Status Update on Commercial Cannabis Export Business

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is reporting on its commercial cannabis operations out of Colombia. According to the status update, the company exported an estimated 1,000 kilograms of commercial cannabis dry flower and derivatives to Europe and the United States in the fourth quarter of 2022; the company also received an updated cannabis export and production quota from the Colombian government, which included the addition of four additional proprietary genetics and increased production for domestic medical markets. The company noted that this activity is a result of the full…

Continue Reading

ThursdayJan 05, 2023 10:57 am

NetworkNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Announces Participation in Upcoming Biotech Showcase

BiondVax Pharmaceuticals (NASDAQ: BVXV) CEO Amir Reichman will be presenting at the Biotech Showcase Conference, scheduled for Jan. 9–11, 2023. The conference is being held in San Francisco during the J.P. Morgan 41st annual Healthcare Conference. BiondVax board chair Mark Germain will also be available throughout the conference to meet with potential partners, collaborators and investors. BiondVax is a biotech company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases. Reichman’s presentation, which will focus on recent successful preclinical in vivo trial results of BiondVax’s inhaled COVID-19 therapy, is slated for…

Continue Reading

ThursdayJan 05, 2023 10:41 am

NetworkNewsBreaks – SideChannel Inc. (SDCH) Featured on ‘Cyber for Hire’ Podcast

SideChannel (OTCQB: SDCH) was featured in a recent “Cyber for Hire – The Managed Security Podcast” published by SC Media. The piece delves into factors to consider when paring a company with a fractional or virtual CISO, looking at how to find a harmonious match. SideChannel’s founder and CEO Brian Haugli joined program co-hosts Bradley Barth and Ryan Morris to discuss the facets that go into the role or service to successfully make the solution work for a client long term. “I’ve been across the whole spectrum… Starting and building the company that I’m in, SideChannel, I started out as…

Continue Reading

WednesdayJan 04, 2023 1:49 pm

NetworkNewsBreaks – Universal Ibogaine Inc. (TSX.V: IBO) Recaps 2022, Eyes 2023 as ‘Pivotal Year’

Universal Ibogaine (TSX.V: IBO) (“UI”), a life sciences company with a mission to transform the addiction treatment industry with medicalized ibogaine-centered care, today provided a year-end summary of 2022 accomplishments. “2022 was a busy year of behind-the-scenes activity laying the foundations with Health Canada in preparation for the planned clinical trial application and sourcing the related ibogaine drug supply,” said Nick Karos, chief executive officer and board member of Universal Ibogaine. “We are finalizing discussions with several potential funding partners and intend on closing the second round of our current convertible debt financing very shortly. 2023 will be a pivotal…

Continue Reading

WednesdayJan 04, 2023 1:37 pm

NetworkNewsBreaks – Vision Energy Corp.’s (VENG) Pioneering Terminal Set to Accelerate Energy Transition

Vision Energy (OTCQB: VENG) recently entered into a corporation agreement with Linde Engineering to accelerate efforts for the company’s pioneering Green Energy Terminal in the North Sea Port of Vlissingen, the Netherlands. “Linde Engineering, a leading global industrial gases and engineering company with 2021 sales of $31 billion, will deliver preliminary Front-End Engineering and Design (‘FEED’) services to the project including design and engineering of 150,000 cubic meters (‘CBM’) of green ammonia (‘NH3’) storage, truck and barge loading facilities, ship loading and unloading facilities, as well as utilities, infrastructure and buildings… Vision Energy is in the advanced stages of planning…

Continue Reading

WednesdayJan 04, 2023 1:18 pm

NetworkNewsBreaks – CubCrafters Inc.’s Distinctiveness in Backcountry Aviation Increases Demand for Its Aircraft

CubCrafters, the leading designer and manufacturer of light-sport, experimental and Part 23 certified backcountry aircraft, has been modeled around a culture of innovation. This, coupled with the dedication and output of its now more than 200 highly skilled personnel, has propelled the company to be a leader in its market segment. “This status is evidenced by several parameters, including CubCrafters’ average aircraft revenue per customer, which has grown from just over $5 million in 2001 to over $30 million in 2021, according to the company’s Regulation A+ presentation. In fact, the company reported resilient sales as well as a growing…

Continue Reading

WednesdayJan 04, 2023 12:18 pm

NetworkNewsBreaks – IBN Launches Customized Investor Relations Solution

IBN, a multifaceted financial news and publishing company for private and public entities, today announced the launch of Investor Relations Plus (+), its customized IR solution designed to support both issuers and IR professionals. IBN continually works to adapt to the evolving needs of its client partners, and with offerings such as press release enhancement through InvestorWire, gleans insight from traditional PR professionals and IR firms while strengthening its value proposition for both public and privately held companies operating across a wide spectrum of industries. “Many of the investor relations firms and professionals we’ve worked alongside over the past 17+…

Continue Reading

WednesdayJan 04, 2023 10:52 am

NetworkNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Set to Begin IGC-AD1 Phase 2 Trials at Sites Throughout Canada

India Globalization Capital (NYSE American: IGC) today announced its receipt of a no objection letter from Health Canada for approval of its “Phase 2, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial of the Safety and Efficacy of IGC-AD1 on Agitation in Participants with Dementia due to Alzheimer’s Disease.” The letter provides the acknowledgement of IGC-AD1’s drug candidacy and the authority to proceed with phase 2 trials in Canada. “We are pleased to have received this no objection letter from Health Canada, which allows us to begin phase 2 trials on our drug formulation IGC-AD1 at sites throughout Canada,” said Ram Mukunda, CEO…

Continue Reading